This report contains market size and forecasts of Hirschsprung Disease Treatment in Global, including the following market information:
Global Hirschsprung Disease Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Hirschsprung Disease Treatment market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Anti-Infective Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hirschsprung Disease Treatment include Pfizer, Sanofi, Bayer Healthcare, Johnson and Johnson, Merck and Co., Novartis AG, Bristol-Myers Squibb, Astellas Pharma and Abbott, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Hirschsprung Disease Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hirschsprung Disease Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Hirschsprung Disease Treatment Market Segment Percentages, by Type, 2021 (%)
Anti-Infective Drugs
Antiemetic
Pain Reliever
Global Hirschsprung Disease Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Hirschsprung Disease Treatment Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Others
Global Hirschsprung Disease Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Hirschsprung Disease Treatment Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hirschsprung Disease Treatment revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Hirschsprung Disease Treatment revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Sanofi
Bayer Healthcare
Johnson and Johnson
Merck and Co.
Novartis AG
Bristol-Myers Squibb
Astellas Pharma
Abbott
Cipla Ltd.
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Hirschsprung Disease Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hirschsprung Disease Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hirschsprung Disease Treatment Overall Market Size
2.1 Global Hirschsprung Disease Treatment Market Size: 2021 VS 2028
2.2 Global Hirschsprung Disease Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hirschsprung Disease Treatment Players in Global Market
3.2 Top Global Hirschsprung Disease Treatment Companies Ranked by Revenue
3.3 Global Hirschsprung Disease Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hirschsprung Disease Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hirschsprung Disease Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hirschsprung Disease Treatment Players in Global Market
3.6.1 List of Global Tier 1 Hirschsprung Disease Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Hirschsprung Disease Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Hirschsprung Disease Treatment Market Size Markets, 2021 & 2028
4.1.2 Anti-Infective Drugs
4.1.3 Antiemetic
4.1.4 Pain Reliever
4.2 By Type - Global Hirschsprung Disease Treatment Revenue & Forecasts
4.2.1 By Type - Global Hirschsprung Disease Treatment Revenue, 2017-2022
4.2.2 By Type - Global Hirschsprung Disease Treatment Revenue, 2023-2028
4.2.3 By Type - Global Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hirschsprung Disease Treatment Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Hirschsprung Disease Treatment Revenue & Forecasts
5.2.1 By Application - Global Hirschsprung Disease Treatment Revenue, 2017-2022
5.2.2 By Application - Global Hirschsprung Disease Treatment Revenue, 2023-2028
5.2.3 By Application - Global Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Hirschsprung Disease Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hirschsprung Disease Treatment Revenue & Forecasts
6.2.1 By Region - Global Hirschsprung Disease Treatment Revenue, 2017-2022
6.2.2 By Region - Global Hirschsprung Disease Treatment Revenue, 2023-2028
6.2.3 By Region - Global Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Hirschsprung Disease Treatment Revenue, 2017-2028
6.3.2 US Hirschsprung Disease Treatment Market Size, 2017-2028
6.3.3 Canada Hirschsprung Disease Treatment Market Size, 2017-2028
6.3.4 Mexico Hirschsprung Disease Treatment Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Hirschsprung Disease Treatment Revenue, 2017-2028
6.4.2 Germany Hirschsprung Disease Treatment Market Size, 2017-2028
6.4.3 France Hirschsprung Disease Treatment Market Size, 2017-2028
6.4.4 U.K. Hirschsprung Disease Treatment Market Size, 2017-2028
6.4.5 Italy Hirschsprung Disease Treatment Market Size, 2017-2028
6.4.6 Russia Hirschsprung Disease Treatment Market Size, 2017-2028
6.4.7 Nordic Countries Hirschsprung Disease Treatment Market Size, 2017-2028
6.4.8 Benelux Hirschsprung Disease Treatment Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Hirschsprung Disease Treatment Revenue, 2017-2028
6.5.2 China Hirschsprung Disease Treatment Market Size, 2017-2028
6.5.3 Japan Hirschsprung Disease Treatment Market Size, 2017-2028
6.5.4 South Korea Hirschsprung Disease Treatment Market Size, 2017-2028
6.5.5 Southeast Asia Hirschsprung Disease Treatment Market Size, 2017-2028
6.5.6 India Hirschsprung Disease Treatment Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Hirschsprung Disease Treatment Revenue, 2017-2028
6.6.2 Brazil Hirschsprung Disease Treatment Market Size, 2017-2028
6.6.3 Argentina Hirschsprung Disease Treatment Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hirschsprung Disease Treatment Revenue, 2017-2028
6.7.2 Turkey Hirschsprung Disease Treatment Market Size, 2017-2028
6.7.3 Israel Hirschsprung Disease Treatment Market Size, 2017-2028
6.7.4 Saudi Arabia Hirschsprung Disease Treatment Market Size, 2017-2028
6.7.5 UAE Hirschsprung Disease Treatment Market Size, 2017-2028
7 Players Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Hirschsprung Disease Treatment Major Product Offerings
7.1.4 Pfizer Hirschsprung Disease Treatment Revenue in Global Market (2017-2022)
7.1.5 Pfizer Key News
7.2 Sanofi
7.2.1 Sanofi Corporate Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Hirschsprung Disease Treatment Major Product Offerings
7.2.4 Sanofi Hirschsprung Disease Treatment Revenue in Global Market (2017-2022)
7.2.5 Sanofi Key News
7.3 Bayer Healthcare
7.3.1 Bayer Healthcare Corporate Summary
7.3.2 Bayer Healthcare Business Overview
7.3.3 Bayer Healthcare Hirschsprung Disease Treatment Major Product Offerings
7.3.4 Bayer Healthcare Hirschsprung Disease Treatment Revenue in Global Market (2017-2022)
7.3.5 Bayer Healthcare Key News
7.4 Johnson and Johnson
7.4.1 Johnson and Johnson Corporate Summary
7.4.2 Johnson and Johnson Business Overview
7.4.3 Johnson and Johnson Hirschsprung Disease Treatment Major Product Offerings
7.4.4 Johnson and Johnson Hirschsprung Disease Treatment Revenue in Global Market (2017-2022)
7.4.5 Johnson and Johnson Key News
7.5 Merck and Co.
7.5.1 Merck and Co. Corporate Summary
7.5.2 Merck and Co. Business Overview
7.5.3 Merck and Co. Hirschsprung Disease Treatment Major Product Offerings
7.5.4 Merck and Co. Hirschsprung Disease Treatment Revenue in Global Market (2017-2022)
7.5.5 Merck and Co. Key News
7.6 Novartis AG
7.6.1 Novartis AG Corporate Summary
7.6.2 Novartis AG Business Overview
7.6.3 Novartis AG Hirschsprung Disease Treatment Major Product Offerings
7.6.4 Novartis AG Hirschsprung Disease Treatment Revenue in Global Market (2017-2022)
7.6.5 Novartis AG Key News
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Corporate Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Hirschsprung Disease Treatment Major Product Offerings
7.7.4 Bristol-Myers Squibb Hirschsprung Disease Treatment Revenue in Global Market (2017-2022)
7.7.5 Bristol-Myers Squibb Key News
7.8 Astellas Pharma
7.8.1 Astellas Pharma Corporate Summary
7.8.2 Astellas Pharma Business Overview
7.8.3 Astellas Pharma Hirschsprung Disease Treatment Major Product Offerings
7.8.4 Astellas Pharma Hirschsprung Disease Treatment Revenue in Global Market (2017-2022)
7.8.5 Astellas Pharma Key News
7.9 Abbott
7.9.1 Abbott Corporate Summary
7.9.2 Abbott Business Overview
7.9.3 Abbott Hirschsprung Disease Treatment Major Product Offerings
7.9.4 Abbott Hirschsprung Disease Treatment Revenue in Global Market (2017-2022)
7.9.5 Abbott Key News
7.10 Cipla Ltd.
7.10.1 Cipla Ltd. Corporate Summary
7.10.2 Cipla Ltd. Business Overview
7.10.3 Cipla Ltd. Hirschsprung Disease Treatment Major Product Offerings
7.10.4 Cipla Ltd. Hirschsprung Disease Treatment Revenue in Global Market (2017-2022)
7.10.5 Cipla Ltd. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Hirschsprung Disease Treatment Market Opportunities & Trends in Global Market
Table 2. Hirschsprung Disease Treatment Market Drivers in Global Market
Table 3. Hirschsprung Disease Treatment Market Restraints in Global Market
Table 4. Key Players of Hirschsprung Disease Treatment in Global Market
Table 5. Top Hirschsprung Disease Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hirschsprung Disease Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hirschsprung Disease Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hirschsprung Disease Treatment Product Type
Table 9. List of Global Tier 1 Hirschsprung Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hirschsprung Disease Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Hirschsprung Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hirschsprung Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hirschsprung Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Hirschsprung Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hirschsprung Disease Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hirschsprung Disease Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Hirschsprung Disease Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hirschsprung Disease Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hirschsprung Disease Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hirschsprung Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hirschsprung Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hirschsprung Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hirschsprung Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hirschsprung Disease Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Hirschsprung Disease Treatment Product Offerings
Table 32. Pfizer Hirschsprung Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Hirschsprung Disease Treatment Product Offerings
Table 35. Sanofi Hirschsprung Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Bayer Healthcare Corporate Summary
Table 37. Bayer Healthcare Hirschsprung Disease Treatment Product Offerings
Table 38. Bayer Healthcare Hirschsprung Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Johnson and Johnson Corporate Summary
Table 40. Johnson and Johnson Hirschsprung Disease Treatment Product Offerings
Table 41. Johnson and Johnson Hirschsprung Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Merck and Co. Corporate Summary
Table 43. Merck and Co. Hirschsprung Disease Treatment Product Offerings
Table 44. Merck and Co. Hirschsprung Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Novartis AG Corporate Summary
Table 46. Novartis AG Hirschsprung Disease Treatment Product Offerings
Table 47. Novartis AG Hirschsprung Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Corporate Summary
Table 49. Bristol-Myers Squibb Hirschsprung Disease Treatment Product Offerings
Table 50. Bristol-Myers Squibb Hirschsprung Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Astellas Pharma Corporate Summary
Table 52. Astellas Pharma Hirschsprung Disease Treatment Product Offerings
Table 53. Astellas Pharma Hirschsprung Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Abbott Corporate Summary
Table 55. Abbott Hirschsprung Disease Treatment Product Offerings
Table 56. Abbott Hirschsprung Disease Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Cipla Ltd. Corporate Summary
Table 58. Cipla Ltd. Hirschsprung Disease Treatment Product Offerings
Table 59. Cipla Ltd. Hirschsprung Disease Treatment Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Hirschsprung Disease Treatment Segment by Type in 2021
Figure 2. Hirschsprung Disease Treatment Segment by Application in 2021
Figure 3. Global Hirschsprung Disease Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hirschsprung Disease Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hirschsprung Disease Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hirschsprung Disease Treatment Revenue in 2021
Figure 8. By Type - Global Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
Figure 12. US Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
Figure 24. China Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hirschsprung Disease Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hirschsprung Disease Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Hirschsprung Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Hirschsprung Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bayer Healthcare Hirschsprung Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson and Johnson Hirschsprung Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Merck and Co. Hirschsprung Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis AG Hirschsprung Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Hirschsprung Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Astellas Pharma Hirschsprung Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Abbott Hirschsprung Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Cipla Ltd. Hirschsprung Disease Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)